What we’re reading, November 14, 2016: President-elect Donald Trump may keep 2 popular components of the Affordable Care Act; the Department of Veterans Affairs will introduce an online appointment scheduling app; Pfizer drops price of pneumococcal vaccine for humanitarian groups.
President-elect Donald J. Trump hinted that he may be open to preserving some of the most popular components of the Affordable Care Act (ACA). Trump told The Wall Street Journal that he is in favor of keeping the prohibition against insurers denying patients coverage due to pre-existing conditions and the provision that allows parents to keep their children on their insurance until the age of 26. This shift from his campaign promise to completely repeal the ACA came after a meeting with President Barack Obama at the White House just 2 days after the election.
Beginning in January, the Department of Veterans Affairs (VA) will allow patients to set up primary care appointments via an app on their computers or mobile devices. The online scheduling initiative will later expand to include mental health, optometry, and audiology appointments. The move is an effort to alleviate the long wait times that are currently under investigation by the VA’s Office of Inspector General.
Pfizer has lowered the price of its pneumococcal vaccine for humanitarian organizations, but some groups working to vaccinate poor countries say it is still too expensive. A 3-dose treatment of Prevnar will now cost $9.30 per child, almost twice the $5 cost called for by Doctors without Borders. In a statement, the nonprofit group called the price decrease “a step in the right direction” and said it hopes Pfizer will continue to “extend its efforts to developing countries.”
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More